- Report
- April 2025
- 147 Pages
Global
From €3549EUR$3,999USD£3,079GBP
- Report
- March 2025
- 149 Pages
Global
From €3549EUR$3,999USD£3,079GBP
- Report
- October 2025
Global
From €4348EUR$4,900USD£3,773GBP
- Report
- January 2026
- 182 Pages
Global
From €3495EUR$3,939USD£3,033GBP
- Report
- January 2026
- 471 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 197 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 179 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 189 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 177 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 368 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 486 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 288 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 279 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 476 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 375 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 464 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 280 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 368 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 451 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 192 Pages
Global
From €5191EUR$5,850USD£4,504GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more